Condition: Open Midline Laparotomy · Sponsor: C. R. Bard
This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
This description comes directly from the study's public registry record.
Amanda Resendes, MBA · 401-209-7141 · amanda.resendes@bd.com
Jaime Ritter, MPH · 404-327-1221 · jaime.ritter@bd.com
Always discuss trial participation with your own doctor first.
| Dignity Health | Phoenix, Arizona, United States | Recruiting |
| Keck Medical Center of USC | Los Angeles, California, United States | Withdrawn |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Active Not Recruiting |
| St. Francis Hospital and Medical Center | Hartford, Connecticut, United States | Withdrawn |
| Emory University | Atlanta, Georgia, United States | Terminated |
| OSF Saint Francis Medical Center | Peoria, Illinois, United States | Active Not Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Active Not Recruiting |
| University of Kentucky Research Foundation | Lexington, Kentucky, United States | Recruiting |
| Tulane University School of Medicine | New Orleans, Louisiana, United States | Recruiting |
| Boston Medical Center | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Withdrawn |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03911700